VEGF increases blood-brain barrier permeability to Evans blue dye and tetanus toxin fragment C but not adeno-associated virus in ALS mice

Brain Research

Volumn 1234, Issue , 2008, Pages 198-205

  Ay, Ilknur ^a   Francis, Jonathan W ^a   Brown Jr , Robert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

AAV2 5; BBB; Evans blue dye; SOD1G93A mice; Tetanus toxin fragment C; VEGF

Indexed keywords

BETA GALACTOSIDASE; EVANS BLUE; TETANUS TOXIN; VASCULOTROPIN;

ADENO ASSOCIATED VIRUS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN STEM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ADENOVIRIDAE; ALPHA-GALACTOSIDASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; COLORING AGENTS; DATA INTERPRETATION, STATISTICAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVANS BLUE; FEMALE; LAC OPERON; MALE; MICE; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SPINAL CORD; SUPEROXIDE DISMUTASE; TETANUS TOXIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ADENO-ASSOCIATED VIRUS; MUS; RODENTIA;

EID: 52049111900     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.121     Document Type: Article

References (32)

1. Benn S.C., Ay I., Bastia E., Chian R.J., Celia S.A., Pepinsky R.B., Fishman P.S., Brown Jr. R.H., and Francis J.W. Tetanus toxin fragment C fusion facilitates protein delivery to CNS neurons from cerebrospinal fluid in mice. J. Neurochem. 95 (2005) 1118-1131
2. Bhattacharjee A.K., Kondoh T., Nagashima T., Ikeda M., Ehara K., and Tamaki N. Quantitative analysis of papaverine-mediated blood-brain barrier disruption in rats. Biochem. Biophys. Res. Commun. 289 (2001) 548-552
3. Bizzini B., Stoeckel K., and Schwab M. An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems. J. Neurochem. 28 (1977) 529-542
4. Burger C., Gorbatyuk O.S., Velardo M.J., Peden C.S., Williams P., Zolotukhin S., Reier P.J., Mandel R.J., and Muzyczka N. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10 (2004) 302-317
5. Chi O.Z., Hunter C., Liu X., and Weiss H.R. Effects of VEGF and nitric oxide synthase inhibition on blood-brain barrier disruption in the ischemic and non-ischemic cerebral cortex. Neurol. Res. 27 (2005) 864-868
6. Darland D.C., and D'Amore P.A. Blood vessel maturation: vascular development comes of age. J. Clin. Invest. 103 (1999) 157-158
7. de Boer A.G., and Gaillard P.J. Strategies to improve drug delivery across the blood-brain barrier. Clin. Pharmacokinet. 46 (2007) 553-576
8. Dobrogowska D.H., Lossinsky A.S., Tarnawski M., and Vorbrodt A.W. Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. J. Neurocytol. 27 (1998) 163-173
9. Doolittle N.D., Miner M.E., Hall W.A., Siegal T., Jerome E., Osztie E., McAllister L.D., Bubalo J.S., Kraemer D.F., Fortin D., Nixon R., Muldoon L.L., and Neuwelt E.A. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 88 (2000) 637-647
10. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat. Med. 9 (2003) 669-676
11. Fishman P.S., and Carrigan D.R. Motoneuron uptake from the circulation of the binding fragment of tetanus toxin. Arch. Neurol. 45 (1988) 558-561
12. Fishman P.S., Savitt J.M., and Farrand D.A. Enhanced CNS uptake of systemically administered proteins through conjugation with tetanus C-fragment. J. Neurol. Sci. 98 (1990) 311-325
13. Garbuzova-Davis S., Haller E., Saporta S., Kolomey I., Nicosia S.V., and Sanberg P.R. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res. 1157 (2007) 126-137
14. Gregorevic P., Blankinship M.J., Allen J.M., Crawford R.W., Meuse L., Miller D.G., Russell D.W., and Chamberlain J.S. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat. Med. 10 (2004) 828-834
15. Hildinger M., Auricchio A., Gao G., Wang L., Chirmule N., and Wilson J.M. Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J. Virol. 75 (2001) 6199-6203
16. Kroll R.A., and Neuwelt E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 42 (1998) 1083-1099 discussion 1099-100
17. Lee S.W., Kim W.J., Choi Y.K., Song H.S., Son M.J., Gelman I.H., Kim Y.J., and Kim K.W. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat. Med. 9 (2003) 900-906
18. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit E., and Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156 (2000) 965-976
19. Mayhan W.G. VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase/cGMP-dependent pathway. Am. J. Physiol. 276 (1999) C1148-1153
20. Muldoon L.L., Soussain C., Jahnke K., Johanson C., Siegal T., Smith Q.R., Hall W.A., Hynynen K., Senter P.D., Peereboom D.M., and Neuwelt E.A. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J. Clin. Oncol. 25 (2007) 2295-2305
21. Nag S., Takahashi J.L., and Kilty D.W. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 56 (1997) 912-921
22. Pardridge W.M. Drug targeting to the brain. Pharm. Res. 24 (2007) 1733-1744
23. Rite I., Machado A., Cano J., and Venero J.L. Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J. Neurochem. 101 (2007) 1567-1582
24. Roberts W.G., and Palade G.E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108 Pt 6 (1995) 2369-2379
25. Tilton R.G., Chang K.C., LeJeune W.S., Stephan C.C., Brock T.A., and Williamson J.R. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF. Invest. Ophthalmol. Vis. Sci. 40 (1999) 689-696
26. Uyama O., Okamura N., Yanase M., Narita M., Kawabata K., and Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cereb. Blood Flow. Metab. 8 (1988) 282-284
27. van Bruggen N., Thibodeaux H., Palmer J.T., Lee W.P., Fu L., Cairns B., Tumas D., Gerlai R., Williams S.P., van Lookeren Campagne M., and Ferrara N. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104 (1999) 1613-1620
28. Weindl A. Neuroendocrine Aspects of Circumventricular Organs (1973), Oxford University Press, New York
29. Wolman M., Klatzo I., Chui E., Wilmes F., Nishimoto K., Fujiwara K., and Spatz M. Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol. (Berl). 54 (1981) 55-61
30. Young P.P., Fantz C.R., and Sands M.S. VEGF disrupts the neonatal blood-brain barrier and increases life span after non-ablative BMT in a murine model of congenital neurodegeneration caused by a lysosomal enzyme deficiency. Exp. Neurol. 188 (2004) 104-114
31. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C., Bruggen N., and Chopp M. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106 (2000) 829-838
32. Zhang Z.G., Zhang L., Tsang W., Soltanian-Zadeh H., Morris D., Zhang R., Goussev A., Powers C., Yeich T., and Chopp M. Correlation of VEGF and angiopoietin expression with disruption of blood-brain barrier and angiogenesis after focal cerebral ischemia. J. Cereb. Blood Flow. Metab. 22 (2002) 379-392